CSIRO Biomanufacturing |
Biologics and Vaccines |
TIA |
Patrick James |
Judy Scoble |
National Biologics Facility (UQ) |
Biologics and Vaccines |
TIA |
Martina Jones |
|
Biologics Innovation Facility (UTS) |
Biologics and Vaccines |
TIA |
Andrew Care |
|
Protein Expression Facility (PEF) |
Biologics and Vaccines |
TIA |
David Owen |
|
Recombinant Products Facility (UNSW RPF) |
Biologics and Vaccines |
TIA |
Helene Lebhar |
Christopher Marquis |
Cell & Tissue Therapies WA (Royal Perth Hospital) |
Cell & Gene Therapies |
TIA |
Zlatibor Velickovic |
|
Cell & Molecular Therapies (Royal Prince Alfred Hospital) |
Cell & Gene Therapies |
TIA |
Sharon Sagnella |
|
Centre of Excellence in Cellular Immunotherapy (Peter Mac) |
Cell & Gene Therapies |
TIA |
Gretchen Poortinga |
|
Functional Genomics South Australia (Uni of Adelaide) |
Cell & Gene Therapies |
TIA |
Jason Gummow |
Simon Barry |
Cell Therapies Pty Ltd |
Cell & Gene Therapies |
TIA |
Jennifer Hollands |
|
Q-Gen Cell Therapeutics (QIMR Berghofer) |
Cell & Gene Therapies |
TIA |
Darron Laing |
|
Sydney Cell and Gene Therapy (Westmead Precinct) |
Cell & Gene Therapies |
TIA |
Leighton Clancy |
|
Vector and Genome Engineering Facility (CMRI) |
Cell & Gene Therapies |
TIA |
Betty Kao |
|
RNA Innovation Foundry (UWA) |
RNA Products |
TIA |
Archa Fox |
Olga Shimoni |
BASE Facility (UQ) |
RNA Products |
TIA |
Tim Mercer |
Rachel Chang |
mRNA CORE (Monash) |
RNA Products |
TIA |
Colin Pouton |
Emily Pilkington |
RNA Institute (UNSW) |
RNA Products |
TIA |
Palli Thordarson |
Joshua Peterson |
Australian Translational Medicinal Chemistry Facility (Monash University) |
Small Molecule Therapeutics |
TIA |
Paul Stupple |
Leanne Hawkey |
Centre for Drug Candidate Optimisation (Monash University) |
Small Molecule Therapeutics |
TIA |
Joseph Nicolazzo |
Alex Stupple |
Centre for Integrated Preclinical Drug Development (UQ) |
Small Molecule Therapeutics |
TIA |
Maree Smith |
Andy Kuo |
Compounds Australia (Griffith University) |
Small Molecule Therapeutics |
TIA |
Rebecca Lang |
Nyssa Drinkwater |
Qld Emory Drug Discovery Initiative |
Small Molecule Therapeutics |
TIA |
Andrew Harvey |
Brian Dymock |
CSIRO Biomanufacturing |
Small Molecule Therapeutics |
TIA |
Mark York |
Charlotte Williams |
ACRF Drug Discovery Centre for Childhood Cancer (Children's Cancer Institute) |
High Throughput Screening |
TIA |
Tim Failes |
|
ANU Centre for Therapeutic Discovery (ANU) |
High Throughput Screening |
TIA / Phenomics Australia |
Amee George |
|
Cell Function & Screening Facility (VCCRI Innovation Centre) |
High Throughput Screening |
TIA |
Jacek Kolanowski |
|
Community for Open Antimicrobial Drug Discovery (UQ) |
High Throughput Screening |
TIA |
Johannes Zuegg |
Mark Blaskovich |
Functional Genomics South Australia (Uni of Adelaide) |
High Throughput Screening |
Phenomics Australia |
Jason Gummow |
Simon Barry |
Griffith Discovery Biology (Griffith University) |
High Throughput Screening |
TIA |
Vicky Avery |
|
IBG Nathan Mass Spec Facility (Griffith University) |
High Throughput Screening |
TIA |
Wendy Loa |
|
Monash Fragment Platform (Monash University) |
High Throughput Screening |
TIA |
Luke Adams |
Martin Scanlon |
Monash Functional Genomics Platform (Monash University) |
High Throughput Screening |
Phenomics Australia |
Sefi Rosenbluh |
|
National Drug Discovery Centre (WEHI) |
High Throughput Screening |
TIA |
Jeff Mitchell |
Kym Lowes |
Stafford Fox Drug Discovery Facility (MCRI) |
High Throughput Screening |
TIA |
Alejandro Hidalgo Gonzalez |
|
Victorian Centre for Functional Genomics (Peter Mac) |
High Throughput Screening |
TIA / Phenomics Australia |
Kaylene Simpson |
|
Induced Pluripotent Stem Cell Derivation & CRISPR Gene Editing Facility (MCRI) |
In vitro genome engineering and disease modelling |
Phenomics Australia |
Sara Howden |
|
Stem Cell Disease Modelling Laboratory (Uni of Melbourne) |
In vitro genome engineering and disease modelling |
Phenomics Australia |
Alice Pébay |
|
Genome Engineering and Disease Modelling Service (UQ) |
In vitro genome engineering and disease modelling |
Phenomics Australia |
Ernst Wolvetang |
|
Australian Organoid Facility (UQ) |
In vitro genome engineering and disease modelling |
Phenomics Australia |
Nathan Godde |
|
Stem Cell Production Facility (VCCRI Innovation Centre) |
In vitro genome engineering and disease modelling |
Phenomics Australia |
Jacek Kolanowski |
|
Translational Cancer Research Program (Harry Perkins Institute of Medical Research) |
In vitro genome engineering and disease modelling |
Phenomics Australia |
Louise Winteringham |
|
Monash Organoid Program (Monash University) |
In vitro genome engineering and disease modelling |
Phenomics Australia |
Thierry Jarde |
|
Monash Genome Modification Platform (Monash University) |
Biobanking and in vivo genome engineering and disease modelling |
Phenomics Australia |
Alexander Combes |
|
The Australian Phenome Bank (ANU) |
Biobanking and in vivo genome engineering and disease modelling |
Phenomics Australia |
Nathalie Doucet |
|
Melbourne Advanced Genome Editing Centre (ONJCRI) |
Biobanking and in vivo genome engineering and disease modelling |
Phenomics Australia |
Andrew Kueh |
|
South Australia Genome Editing Facility (Uni of Adelaide) |
Biobanking and in vivo genome engineering and disease modelling |
Phenomics Australia |
Paul Thomas |
|
Australian Transgenic Drosophila Facility |
Biobanking and in vivo genome engineering and disease modelling |
Phenomics Australia |
Kieran Harvey |
|
Histopathology and Digital Slide Service (Uni of Melbourne) |
Pathology |
Phenomics Australia |
Janet Keast |
|
National Deuteration Facility |
Stable Isotope Labelling |
ANSTO |
Tamim Darwish |
Karyn Wilde |
Agilex Biolabs |
GLP toxicology |
TIA |
Ricky Matias |
Jason Valentine |
Preclinical, Imaging and Research Laboratories (PIRL) |
GLP toxicology |
TIA |
Adam O'Connell |
Tamara Varcoe |